FDA schedules panel meeting on AquaBounty's biotech salmon

08/25/2010 | Los Angeles Times (tiered subscription model)

The FDA's Veterinary Medicine Advisory Committee will hold a meeting on Sept. 19 and 20 to evaluate scientific data and determine whether AquaBounty Technologies' biotech salmon should be approved for human consumption. The FDA also scheduled a public meeting for Sept. 21 to determine whether to label the product as being genetically modified.

View Full Article in:

Los Angeles Times (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Food & Beverage

Job Title Company Location
Staff Assistant, Food Trucks/Commissary Manager
University of Massachusetts Amherst
Amherst, MA
Retail Food Services Manager
University of Massachusetts Amherst
Amherst, MA
Executive Pastry Chef
Princeton University
Princeton, NJ